Monday, August 20, 2018
Company News: Page (1) of 1 - 02/14/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Cardiac Biomarkers Market Outlook 2025: Top Companies, Trends and Future Prospects Details for Business Development

(February 14, 2018)

Cardiac biomarkers are protein based molecules that are released into the blood stream when heart encounters any sort of damage of stress. These cardiac biomarkersare measurable and quantifiable biological parameters that serves as indicator for prognostic and diagnostic purposes associated to cardiac conditions. Cardiac biomarkers assess the heart function and assist in analysing the complexity and severity of procedure that further require in diagnosing the cardiovascular disease. Cardiac biomarkers are used as risk satisfaction in cardiovascular disease such as Acute Myocardial Infraction, Peripheral Artery Disease, acute coronary syndrome, congestive heart failure, Angina Pectoris.  High blood pressure, lack of exercise, unhealthy food habits, smoking and excessive consumption of alcohol, high blood cholesterol, diabetes and obesity are major causes for cardiovascular diseases.

To Get Sample Copy of Report visit @

Market Growth Factors

High sensitivity and accuracy of cardiac biomarkers in early detection of cardiovascular disease, promising characteristics such as specificity, quick outcomes and affordable pricing of cardiac point of care testing is driving the market growth. In addition, technological advancement in development of cardiovascular biomarkers and high prevalence of cardiovascular disease and non-invasive techniques, increase in number of products in pipeline and rising number of product approval are other factors boosting the global cardiac biomarkers market for future growth. However, stringent unmet regulation of government, side effects such as skeletal muscle injury, confirmation in result and complex process restrain the market growth.


The global cardiac biomarker market is categorized on the basis of type of marker, application, location of testing and region. On the basis of type of marker is market is segmented into CREATINE KINASE, Troponins (T, I), Myoglobin, Natriuretic peptides (BNP and NT-proBNP), Ischemia Modified Albumin and others. By application, it is divided into Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Atherosclerosis and Others. Considering location of testing the market is classified into point of care testing and laboratory testing. The troponins type of biomarker is expected to grow at highest rate owing to its immense specificity and efficiency to precisely detect the cardiac events of acute coronary syndrome.

Check Discount on this report @

Regional Analysis

Based on Geography, the global cardiac biomarkers market is studied across North America, Europe, Asia-Pacific and LAMEA. North America is anticipated to account largest share of the market. Factors attributing to the North America’s growth are increased prevalence of cardiovascular diseases, awareness among population regarding cardiac diagnostic solutions along with high demand for cardiac testing. Followed by North America Asia-Pacific is expected to witness speedy growth in the global cardiac biomarkers market mainly owing to rapidly growing population, modernization and increased affordability for highly advanced cardiac treatments.

Competitive Analysis

The key players actively working in the industry of global cardiac biomarkers are Abbott Laboratories, Roche Diagnostics, Alere Inc., Ortho Clinical Diagnostics, Becton, Dickinson and Co., BioMerieux, Siemens Healthcare, Beckman Coulter and Thermo Fisher Scientific.


About Garner Insights:
Garner Insights ( is a Market Intelligence and Business Consulting firm led by professionals with a vast experience and knowledge of the market research industry.

Our vast repository of research reports across various categories, gives you a complete view of the ever-evolving trends and current topics worldwide. Our constant focus is on improving the data and finding innovative methods, which will help your business drive profitable growth.The research methodology is designed to cater all your research needs which is backed by exclusive quantitative and analytics driven intelligence. It consists of primary and secondary methods which is a testimony of the information comprised. The meticulous and distinct data gathering methods are in line with the highest standards of data mining in the industry.

Media Contact
Company Name: Garner Insights
Contact Person: Kevin Thomas
Email: [email protected]
Phone: +1 513 549 5911
City: Pune
Country: India


Page: 1

Related Keywords:Business,Health & Medicine,Pharmaceuticals & Biotech,Services,U.S,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The global connected health device market is expected to reach an estimated $36.1 billion by 2023 and is forecast to grow at a CAGR of 21.1% from 2018 to 2023
  • Global Hemodialysis and Peritoneal Dialysis Market to Witness a CAGR of 5.9% during 2018-2024
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023

  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • /R E P E A T -- Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution/
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines